Strata Oncology

Strata Oncology is a precision oncology company dedicated to providing the best possible treatment for every cancer patient. The company integrates molecular profiling, real-world data, and large-scale clinical trial platforms to identify and deliver optimal drug therapies for cancer patients. StrataNGS® is a comprehensive genomic profiling test characterized by the industry's lowest tumor tissue requirements, allowing more patients to receive the results and treatment they need. We collaborate with major healthcare systems across China, which send biopsy samples from cancer patients to our high-throughput CLIA laboratory for genomic sequencing. Results are provided to oncologists within days, indicating tumor characteristics and matching them with appropriate treatments and drug trials. This accelerates the advancement of personalized medicine—delivering the right drug to the right patient at the right time.